Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
<p>Abstract</p> <p>Oral vaccines, whether living or non-living, viral or bacterial, elicit diminished immune responses or have lower efficacy in developing countries than in developed countries. Here I describe studies with a live oral cholera vaccine that include older children no...
Main Author: | Levine Myron M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Biology |
Online Access: | http://www.biomedcentral.com/1741-7007/8/129 |
Similar Items
-
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days
by: Tew Hui Xian, et al.
Published: (2020-05-01) -
PaxVax CVD 103-HgR single-dose live oral cholera vaccine
by: Myron M. Levine, et al.
Published: (2017-03-01) -
Oral Cholera Vaccine Efficacy and Effectiveness
by: Katerina Rok Song, et al.
Published: (2021-12-01) -
Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam
by: Trach D.D., et al.
Published: (2002-01-01) -
Safety of oral cholera vaccines during pregnancy in developing countries
by: Ashraful Islam Khan, et al.
Published: (2017-10-01)